PFIZER
|
PFIZER Last 5 Year Financial Ratios History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 136.38 | 133.89 | 108.77 | 111.29 | 93.78 |
CEPS(Rs) | 159.44 | 159.03 | 132.68 | 133.85 | 109.39 |
DPS(Rs) | 70.00 | 30.00 | 35.00 | 330.00 | 22.50 |
Book NAV/Share(Rs) | 701.05 | 626.10 | 523.07 | 742.18 | 658.22 |
Tax Rate(%) | 24.28 | 20.74 | 25.59 | 20.76 | 34.98 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 31.60 | 30.79 | 31.82 | 26.62 | 27.17 |
EBIT Margin(%) | 32.71 | 28.86 | 30.56 | 30.37 | 31.79 |
Pre Tax Margin(%) | 32.18 | 28.46 | 29.87 | 29.86 | 31.70 |
PAT Margin (%) | 24.37 | 22.56 | 22.23 | 23.66 | 20.61 |
Cash Profit Margin (%) | 28.49 | 26.79 | 27.12 | 28.46 | 24.04 |
Performance Ratios | |||||
ROA(%) | 16.09 | 17.24 | 13.00 | 12.20 | 11.25 |
ROE(%) | 20.55 | 23.30 | 17.19 | 15.89 | 15.07 |
ROCE(%) | 27.56 | 29.78 | 23.62 | 20.38 | 23.22 |
Asset Turnover(x) | 0.66 | 0.76 | 0.58 | 0.52 | 0.55 |
Sales/Fixed Asset(x) | 1.90 | 2.07 | 1.75 | 1.81 | 1.90 |
Working Capital/Sales(x) | 1.39 | 1.80 | 1.97 | 0.99 | 1.14 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.53 | 0.48 | 0.57 | 0.55 | 0.53 |
Receivable days | 20.98 | 16.89 | 22.89 | 29.15 | 28.62 |
Inventory Days | 61.77 | 59.41 | 70.57 | 69.32 | 59.95 |
Payable days | 109.35 | 114.15 | 176.59 | 212.28 | 250.57 |
Valuation Parameters | |||||
PER(x) | 25.40 | 32.50 | 41.57 | 36.17 | 35.41 |
PCE(x) | 21.73 | 27.36 | 34.08 | 30.07 | 30.36 |
Price/Book(x) | 4.94 | 6.95 | 8.64 | 5.42 | 5.04 |
Yield(%) | 2.02 | 0.69 | 0.77 | 8.20 | 0.68 |
EV/Net Sales(x) | 5.77 | 7.00 | 8.74 | 7.53 | 6.38 |
EV/Core EBITDA(x) | 15.37 | 20.33 | 24.67 | 21.40 | 18.12 |
EV/EBIT(x) | 16.71 | 23.31 | 28.61 | 24.78 | 20.07 |
EV/CE(x) | 3.58 | 4.74 | 6.02 | 3.68 | 3.37 |
M Cap / Sales | 6.54 | 7.62 | 9.24 | 8.56 | 7.30 |
Growth Ratio | |||||
Net Sales Growth(%) | -7.13 | 16.64 | 4.04 | 3.37 | 5.74 |
Core EBITDA Growth(%) | 1.27 | 13.24 | 4.86 | 3.24 | 19.20 |
EBIT Growth(%) | 6.88 | 14.54 | 4.68 | -1.23 | 20.59 |
PAT Growth(%) | 1.86 | 23.10 | -2.26 | 18.66 | 19.16 |
EPS Growth(%) | 1.86 | 23.10 | -2.26 | 18.66 | 19.16 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | - | - |
Current Ratio(x) | 3.79 | 2.77 | 2.46 | 3.49 | 3.05 |
Quick Ratio(x) | 3.16 | 2.24 | 1.92 | 3.00 | 2.61 |
Interest Cover(x) | 62.13 | 73.23 | 44.45 | 59.36 | 384.67 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹18,832.3 Cr | -1.4% | -4.2% | 23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | -1.4% |
-4.2% |
23.2% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses